logo
Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds

Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds

Value-based care results in patients spending more time with their primary care clinician, less time in the hospital, and more frequent preventive care, based on research released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its annual Value-Based Care Report.
Over a decade of Humana's research shows value-based care improves patient outcomes. (Photo: Humana)
The report's data shows that Medicare Advantage (MA) patients receiving care under value-based arrangements saw fewer emergency department visits, fewer inpatient hospitalizations, and received more preventive care screenings.
Clinicians under the traditional fee-for-service model are reimbursed based on the volume of patients and services provided, with no incentive to reduce costly or low-value interventions. The value-based model emphasizes preventive care and incentivizes health outcomes.
'Coordinated care that delivers the right care at the right time must become the standard,' said Dr. Kate Goodrich, Chief Medical Officer at Humana. 'Our report paints a clear picture: value-based practices deliver better patient experiences and health outcomes. Patients spend more time with their primary care clinician, which means more preventive care and better management of chronic diseases, like diabetes and high blood pressure. Seniors in value-based care models receive the care they deserve with a clinician who holistically understands their care needs. At Humana, we are committed to advancing value-based care as the best model for improving health outcomes and the healthcare experience for seniors everywhere.'
A Smarter Healthcare Model
The need to accelerate value-based adoption is more imperative than ever. Clinicians are increasingly experiencing high levels of burnout, while patients struggle with a fragmented healthcare system characterized by disjointed appointments, and lack of coordinated care.
Value-based agreements range from financial rewards to full-risk reimbursement models allowing practices to choose what works best for them. Clinicians are incentivized to prioritize high-value, preventive care to keep patients healthy longer. As practices mature in value-based arrangements, care coordination becomes more effective across care teams, which results in more high value services and fewer unnecessary or duplicative services. With the alignment of financial incentives to delivery of high-quality care, care gaps close and patient engagement increases under an integrated clinical team.
Based on more than a decade of Humana's data, value-based care advances:
Patients spend more time with their primary care clinician and have fewer emergency department and hospital visits, in turn reducing costly, low-value care.
A clinical team-based approach to care coordination - after a hospital stay, between primary care visits, or when beginning a new medication.
A sustainable healthcare system, where patients, clinicians, and payers benefit from the financial stability and better outcomes of value-driven models.
Technology integrations allow for real-time, actionable data at the fingertips of clinicians to eliminate gaps in care.
Key Findings from the report:
Regular primary care appointments mean better prevention and healthcare maintenance. In 2023, value-based care members saw their primary care clinicians 10% more than non-value-based care patients.
VBC Medicare Advantage patients report 90 out of 100 satisfaction with their healthcare provider, per Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data.
Less time spent in the hospital. VBC Medicare Advantage patients saw 32.1% fewer inpatient admissions in 2023 versus those enrolled in Original Medicare.
Humana Medicare Advantage members treated by value-based clinicians experienced 11.6% fewer ER visits and 7.2% fewer admissions than those not in a value-based arrangement.
Humana Medicare Advantage members receive more preventive screenings than those under non-value-based practices across these measures: annual wellness exam, colorectal screening, diabetes eye exam, and mammogram.
Value-based care allows for better chronic disease management. Humana Medicare Advantage members were more likely to receive diabetes care eye exam screenings and to meet blood sugar control measures versus members not in a value-based care arrangement.
Senior-focused primary care organizations (PCOs) combine a VBC model with a care delivery approach tailored for seniors. Black patients visited their senior-focused primary care clinician 39% more and low-income beneficiaries had 21% more visits versus Original Medicare.
Senior-focused primary care patients had 17% more primary care visits, 6% fewer hospitalizations and 11% fewer emergency department (ED) visits.
Value-based arrangements allow for investments in benefits members value most at an affordable price. In 2023, Humana Medicare Advantage value-based arrangements saved 25.8%, in medical costs compared to Original Medicare. Humana invests these savings directly into more member benefits, such as lower premiums, home care, prescription delivery and healthy food cards.
Beyond Primary Care
The new report also spotlights how value-based arrangements in specialty practices positively impact patient outcomes. Humana MA patients aligned to value-based nephrology programs experienced 5% fewer unnecessary hospitalizations versus fee-for-service clinicians.
'We must unite to address clinicians' pain points, creating a system where every stakeholder can prioritize health first,' said George Renaudin, Humana's Insurance President. 'Over a decade of our experience and research shows that providers navigating the shift to value achieve greater success with proactive support, an operational roadmap and actionable data. The path forward is clear: the value-based model is the future – we have seen it in action, and it's the key to sustainable, patient-centered care.'
Humana offers a practical how-to-guide for successful value-driven operations. Real-time, integrated data systems are a first step for any practice in moving toward value. For a sustainable healthcare system, the value-based care model is a necessity for patients and clinicians.
Read Humana's Value-Based Care Report in full here.
About Humana
Humana Inc. (NYSE: HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Cait Crenshaw Whatley
SOURCE: Humana Inc.
Copyright Business Wire 2025.
PUB: 02/05/2025 08:45 AM/DISC: 02/05/2025 08:47 AM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers
UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers

CNBC

time13 minutes ago

  • CNBC

UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers

UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street's expectations, as the company's insurance unit continues to grapple with higher medical costs. The company anticipates it will post 2025 adjusted earnings of at least $16 per share, with revenue of $445.5 billion to $448 billion. Wall Street analysts had expected 2025 adjusted profit of $20.91 per share, and full-year revenue of $449.16 billion, according to consensus estimates from LSEG. Shares of UnitedHealth Group fell more than 3% in premarket trading on Tuesday. The report adds to a growing string of setbacks for the company, which owns the nation's largest and most powerful insurer, UnitedHealthcare, and is often viewed as the industry's bellwether. The stock tumbled in May after the company suspended its 2025 guidance due to higher medical costs and announced the abrupt departure of former CEO Andrew Witty. UnitedHealth Group's report signals that elevated medical costs in Medicare Advantage plans may not ease anytime soon for the broader health insurance industry. UnitedHealthcare, the insurance arm of UnitedHealth Group, is the nation's largest provider of those privately run Medicare plans. Higher expenses in Medicare Advantage plans have dogged insurers over the past year as more seniors return to hospitals to undergo procedures they had delayed during the Covid-19 pandemic, such as joint and hip replacements. Here's what UnitedHealth Group reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Notably, the report comes just days after UnitedHealth revealed it is complying with Department of Justice investigations into its Medicare billing practices. It marks UnitedHealth's first earnings report under new CEO, Stephen Hemsley, who is tasked with restoring investor confidence and turning around a struggling company that has continued to draw heavy public scrutiny in recent months. Shares of UnitedHealth Group are down more than 44% for the year, fueled in part by the DOJ's investigations and its suspended outlook. The company's 2024 wasn't any better. It grappled with the murder of UnitedHealthcare's CEO, Brian Thompson, the torrent of public blowback that followed and a historic cyberattack that affected millions of Americans.

EXCLUSIVE: Humana to offer employees a buyout in form of early retirement option
EXCLUSIVE: Humana to offer employees a buyout in form of early retirement option

Yahoo

time2 hours ago

  • Yahoo

EXCLUSIVE: Humana to offer employees a buyout in form of early retirement option

Humana, the Louisville-based health insurance company, has announced it will begin offering a Voluntary Early Retirement Program to employees. Humana spokesperson Mark Taylor told The Courier Journal the voluntary early retirement option comes as the insurer works to "adjust and evaluate our staffing needs." The buyout announcement comes just days before the company is expected to report its second quarter earnings. Analysts are predicting the company will report a decrease of nearly 9% in earnings per share, according to NASDAQ. In the first quarter of 2025, Humana posted a strong quarter, beating the estimates of Wall Street. "Those who qualify for this voluntary program and decide to take this option will be able to pursue new goals and interests while having the financial support that an early retirement package can help provide," a statement provided by Humana to The Courier Journal said. "We expect this program may be of interest to some eligible employees who have been considering their near-term retirement options, and we will take the utmost care to ensure each eligible employee has the support they need as they consider this next step in their career." Background: Humana CEO talks about company leaving iconic downtown Louisville tower The early retirement buyout option is only available to eligible employees. To be eligible, workers must be at least 50 years old and have at least three years of service with the company, Taylor said. Eligible employees will receive an exit package that includes two weeks of pay per year of service plus an additional amount based on job level. The total payout for any employee would be capped at 52 weeks of pay, Taylor said. In a statement to The Courier Journal, the company said, "positions in some business areas will be excluded from program eligibility." Employees will be able to opt-in to the early retirement option throughout the "next several weeks," the company statement said. Humana offered early retirement for eligible employees in 2017, The Courier Journal previously reported. Following the 2017 voluntary workforce reduction effort, the company went on to lay off 1,300 employees just months later. "At Humana, we are committed to delivering industry-leading care that makes it easier for the millions of people we serve to achieve their best health. In support of this commitment, we evaluate our staffing needs on an ongoing basis and make adjustments when necessary to drive greater organizational efficiency, better meet the needs of our business and create greater value for our members and patients," the company statement said. Other Humana developments in downtown Louisville The iconic Humana Tower at 500 W. Main St. was listed for sale in February, following a 2024 announcement that the company would consolidate its Louisville headquarters into the Humana Waterside and Clocktower, roughly one mile down Main Street. A buyer has not yet been announced. More: Humana making $21M+ in renovations to new downtown Louisville HQ amid consolidation In March, the company started a $21.4 million renovation to the Waterside and Clocktower property, The Courier Journal previously reported. Humana is a major asset to Louisville and draws in roughly $14 billion to the state in economic output and has repeatedly said it remains committed to its hometown. Contact business reporter Olivia Evans at oevans@ or on X, the platform formerly known as Twitter at @oliviamevans_. This article originally appeared on Louisville Courier Journal: Humana offers voluntary early retirement option, buyout to workers Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?
What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?

Business Insider

time2 hours ago

  • Business Insider

What's Ahead for UnitedHealth (UNH) as Stock Drops 44% YTD?

UnitedHealth Group (UNH), the largest healthcare provider, is now one of the worst-hit stocks of 2025. Down 44% year-to-date, UNH stock was dragged down by rising costs in its Medicare Advantage business, a surprise CEO exit, and intensifying federal scrutiny into its billing practices. Currently, investors are looking for updates on the company's progress on the legal and financial front at the Q2 earnings, due July 29. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. What Went Wrong? The selloff in UNH stock began in April when UnitedHealth missed earnings and slashed its full-year guidance. This was followed by the resignation of CEO Andrew Witty in May. Also, last week, the company confirmed it is under both criminal and civil investigations by the Department of Justice. The probe centers on alleged overbilling in its Medicare Advantage program, specifically whether patient diagnoses were inflated to boost government reimbursements. Analysts Are Not That Bearish Despite the turmoil, Wall Street sentiment is mixed but not entirely bearish. Bernstein even named UNH a 'Top Pick,' citing its discounted valuation and long-term earnings potential. Further, the firm expects a doubling of EPS by 2029, driven by sector recovery and company-specific margin recovery. Others are more cautious. Wells Fargo and Truist Financial recently lowered their price targets, citing weak investor sentiment and concerns around Optum Health, UnitedHealth's services arm. All Eyes Are on UNH's Q2 Results Currently, analysts anticipate that Q2 earnings will fall to $4.48 from $6.80 a year ago. Meanwhile, revenue is expected to grow 12.8% to $111.50 billion. The bottom-line drop reflects higher-than-expected medical costs, especially in Medicare Advantage, which have hurt the company's margins. More than the Q2 numbers, investors are focused on CEO Stephen Hemsley offering a roadmap for recovery, including updated 2025 guidance and early signals for 2026. A full-year EPS outlook of below $18 could result in investors losing more confidence and trigger further selling. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, five Holds, and one Sell assigned in the last three months. At $348.12, the average UnitedHealth stock price target implies a 24.11% upside potential.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store